https://www.stuvia.com /us er/papersprimel OMoARc PSD| 327
44l 1O6M9oARcPSD|
327 441 69
https://www.stuvia.com/user/papersprime
TEST BANK
for pharmacotherapeutics for advanced
practice a practical approach 5th edition
, lOMoAR cPSD| 327
44l 1O6M9oARcPSD|
327 441 69
TABLE OF CONTENT o Chapter 1: Issues for the
Practitioner in Drug Therapy
, lOMoAR cPSD| 327 441 69
o Chapter 2: Pharmacokinetic Basis of Therapeutics and
Pharmacodynamic Principles o Chapter 3: Impact of Drug
Interactions and Adverse Events on Therapeutics o Chapter
4: Principles of Pharmacotherapy in Pediatrics, Pregnancy
and Lactation o Chapter 5: Pharmacotherapy Principles in
Older Adults o Chapter 6: Principles of Antimicrobial
Therapy o Chapter 7: Pharmacogenomics
o Chapter 8: The Economics of Pharmacotherapeutics o
Chapter 9: Principles of Pharmacology in Pain Management
o Chapter 10: Pain Management in Opioid Use Disorder
(OUD) Patients o Chapter 11: Cannabis and Pain
Management o Chapter 12: Dermatitis
o Chapter 13: Bacterial, Fungal, and Viral Infections of the
Skin o Chapter 14: Psoriasis
o Chapter 15: Acne Vulgaris and Rosacea o Chapter 16:
Ophthalmic Disorders o Chapter 17: Otitis Media and Otitis
Externa o Chapter 18: Hypertension o Chapter 19:
Hyperlipidemia
o Chapter 20: Chronic Stable Angina and Myocardial
Infarction o Chapter 21: Heart Failure o Chapter 22:
Arrhythmias o Chapter 23: Respiratory Infections
o Chapter 24: Asthma and Chronic Obstructive Pulmonary
Disease o Chapter 25: Gastric, Functional and Inflammatory
Bowel Disorders o Chapter 26: Gastroesophageal Reflux
Disease and Peptic Ulcer Disease o Chapter 27: Liver
Diseases o Chapter 28: Urinary Tract Infection
o Chapter 29: Prostatic Disorders and Erectile Dysfunction o
Chapter 30: Overactive Bladder o Chapter 31: Sexually
Transmitted Infections o Chapter 32: Osteoarthritis and Gout
o Chapter 33: Osteoporosis o Chapter 34: Rheumatoid
Arthritis o Chapter 35: Headaches o Chapter 36: Seizure
Disorders o Chapter 37: Alzheimer’s Disease o Chapter 38:
Parkinson Disease
o Chapter 39: Major Depressive Disorder and Bipolar
Disorders o Chapter 40: Anxiety Disorders o Chapter 41:
Sleep Disorders
o Chapter 42: Attention Deficit Hyperactivity Disorder o
Chapter 43: Substance Use Disorders o Chapter 44:
Diabetes Mellitus
o Chapter 45: Thyroid and Parathyroid Disorders o Chapter
46: Allergies and Allergic Reactions o Chapter 47: Human
Immunodeficiency Virus o Chapter 48: Organ
Transplantation
o Chapter 49: Pharmacotherapy for Select Thromboembolic
Disorders o Chapter 50: Anemias o Chapter 51:
Immunizations o Chapter 52: Smoking Cessation o Chapter
53: Weight Loss o Chapter 54: Contraception
, lOMoAR cPSD| 327 441 69
o Chapter 55: Menopause
o Chapter 56: Vaginitis
Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
ANS: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
ANS: D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
ANS: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include: A. Asking the patient
what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a
prescription D. Following U.S. Drug Enforcement Administration (DEA)
guidelines for
prescribing
ANS: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve
patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
44l 1O6M9oARcPSD|
327 441 69
https://www.stuvia.com/user/papersprime
TEST BANK
for pharmacotherapeutics for advanced
practice a practical approach 5th edition
, lOMoAR cPSD| 327
44l 1O6M9oARcPSD|
327 441 69
TABLE OF CONTENT o Chapter 1: Issues for the
Practitioner in Drug Therapy
, lOMoAR cPSD| 327 441 69
o Chapter 2: Pharmacokinetic Basis of Therapeutics and
Pharmacodynamic Principles o Chapter 3: Impact of Drug
Interactions and Adverse Events on Therapeutics o Chapter
4: Principles of Pharmacotherapy in Pediatrics, Pregnancy
and Lactation o Chapter 5: Pharmacotherapy Principles in
Older Adults o Chapter 6: Principles of Antimicrobial
Therapy o Chapter 7: Pharmacogenomics
o Chapter 8: The Economics of Pharmacotherapeutics o
Chapter 9: Principles of Pharmacology in Pain Management
o Chapter 10: Pain Management in Opioid Use Disorder
(OUD) Patients o Chapter 11: Cannabis and Pain
Management o Chapter 12: Dermatitis
o Chapter 13: Bacterial, Fungal, and Viral Infections of the
Skin o Chapter 14: Psoriasis
o Chapter 15: Acne Vulgaris and Rosacea o Chapter 16:
Ophthalmic Disorders o Chapter 17: Otitis Media and Otitis
Externa o Chapter 18: Hypertension o Chapter 19:
Hyperlipidemia
o Chapter 20: Chronic Stable Angina and Myocardial
Infarction o Chapter 21: Heart Failure o Chapter 22:
Arrhythmias o Chapter 23: Respiratory Infections
o Chapter 24: Asthma and Chronic Obstructive Pulmonary
Disease o Chapter 25: Gastric, Functional and Inflammatory
Bowel Disorders o Chapter 26: Gastroesophageal Reflux
Disease and Peptic Ulcer Disease o Chapter 27: Liver
Diseases o Chapter 28: Urinary Tract Infection
o Chapter 29: Prostatic Disorders and Erectile Dysfunction o
Chapter 30: Overactive Bladder o Chapter 31: Sexually
Transmitted Infections o Chapter 32: Osteoarthritis and Gout
o Chapter 33: Osteoporosis o Chapter 34: Rheumatoid
Arthritis o Chapter 35: Headaches o Chapter 36: Seizure
Disorders o Chapter 37: Alzheimer’s Disease o Chapter 38:
Parkinson Disease
o Chapter 39: Major Depressive Disorder and Bipolar
Disorders o Chapter 40: Anxiety Disorders o Chapter 41:
Sleep Disorders
o Chapter 42: Attention Deficit Hyperactivity Disorder o
Chapter 43: Substance Use Disorders o Chapter 44:
Diabetes Mellitus
o Chapter 45: Thyroid and Parathyroid Disorders o Chapter
46: Allergies and Allergic Reactions o Chapter 47: Human
Immunodeficiency Virus o Chapter 48: Organ
Transplantation
o Chapter 49: Pharmacotherapy for Select Thromboembolic
Disorders o Chapter 50: Anemias o Chapter 51:
Immunizations o Chapter 52: Smoking Cessation o Chapter
53: Weight Loss o Chapter 54: Contraception
, lOMoAR cPSD| 327 441 69
o Chapter 55: Menopause
o Chapter 56: Vaginitis
Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
ANS: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
ANS: D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
ANS: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include: A. Asking the patient
what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a
prescription D. Following U.S. Drug Enforcement Administration (DEA)
guidelines for
prescribing
ANS: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve
patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
